Mark Teo

1.9k total citations
24 papers, 632 citations indexed

About

Mark Teo is a scholar working on Surgery, Oncology and Radiation. According to data from OpenAlex, Mark Teo has authored 24 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 11 papers in Oncology and 6 papers in Radiation. Recurrent topics in Mark Teo's work include Colorectal and Anal Carcinomas (9 papers), Colorectal Cancer Surgical Treatments (8 papers) and Advanced Radiotherapy Techniques (6 papers). Mark Teo is often cited by papers focused on Colorectal and Anal Carcinomas (9 papers), Colorectal Cancer Surgical Treatments (8 papers) and Advanced Radiotherapy Techniques (6 papers). Mark Teo collaborates with scholars based in United Kingdom, Denmark and Netherlands. Mark Teo's co-authors include Anne E. Kiltie, Mehmet Şen, Robin Prestwich, K. Dyker, D. Timothy Bishop, Faye Elliott, David Sebag‐Montefiore, Claire Taylor, Margaret A. Knowles and Robert G. Bristow and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Mark Teo

22 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Teo United Kingdom 13 241 182 178 172 130 24 632
Jay Boyle United States 10 322 1.3× 248 1.4× 179 1.0× 190 1.1× 387 3.0× 22 735
Pedro A. Andrade Filho United States 15 156 0.6× 203 1.1× 181 1.0× 508 3.0× 168 1.3× 23 962
Martin C. Jäckel Germany 13 336 1.4× 210 1.2× 64 0.4× 195 1.1× 391 3.0× 37 629
Hedley Krawitz Australia 12 156 0.6× 287 1.6× 48 0.3× 195 1.1× 239 1.8× 24 560
Ryan J. Brisson United States 12 230 1.0× 203 1.1× 76 0.4× 266 1.5× 330 2.5× 39 558
M.I. Saunders United Kingdom 12 74 0.3× 128 0.7× 91 0.5× 86 0.5× 100 0.8× 30 489
Célia M. Viégas Brazil 10 71 0.3× 283 1.6× 53 0.3× 158 0.9× 134 1.0× 19 477
Shachi Jenny Sharma Germany 14 236 1.0× 110 0.6× 90 0.5× 177 1.0× 311 2.4× 41 543
P. Volling Germany 12 394 1.6× 314 1.7× 89 0.5× 284 1.7× 581 4.5× 36 735
Nancy Y. Lee United States 6 137 0.6× 205 1.1× 51 0.3× 305 1.8× 144 1.1× 7 617

Countries citing papers authored by Mark Teo

Since Specialization
Citations

This map shows the geographic impact of Mark Teo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Teo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Teo more than expected).

Fields of papers citing papers by Mark Teo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Teo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Teo. The network helps show where Mark Teo may publish in the future.

Co-authorship network of co-authors of Mark Teo

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Teo. A scholar is included among the top collaborators of Mark Teo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Teo. Mark Teo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Banfill, Kathryn, Patricia Díez, Sarah Gwynne, et al.. (2025). Royal College of Radiologists Guidance Statements on the Use of Auto-contouring in Radiotherapy. Clinical Oncology. 50. 104004–104004.
2.
Teo, Mark, et al.. (2023). T3 N1 M0 rectal cancer: the optimal initial management is long-course chemoradiotherapy. British journal of surgery. 111(1). 1 indexed citations
3.
Bird, D. J., Matthew Beasley, H. McCallum, et al.. (2021). Patient position verification in magnetic-resonance imaging only radiotherapy of anal and rectal cancers. Physics and Imaging in Radiation Oncology. 19. 72–77. 3 indexed citations
4.
Bird, D. J., H. McCallum, Mark Teo, et al.. (2021). The benefit of MR‐only radiotherapy treatment planning for anal and rectal cancers: A planning study. Journal of Applied Clinical Medical Physics. 22(11). 41–53. 6 indexed citations
6.
Peters, Femke P., Mark Teo, Ane Appelt, et al.. (2020). Mesorectal radiotherapy for early stage rectal cancer: A novel target volume. Clinical and Translational Radiation Oncology. 21. 104–111. 8 indexed citations
7.
Bird, D. J., H. McCallum, Mark Teo, et al.. (2020). Multicentre, deep learning, synthetic-CT generation for ano-rectal MR-only radiotherapy treatment planning. Radiotherapy and Oncology. 156. 23–28. 40 indexed citations
9.
Appelt, Ane, Ellen M. Kerkhof, Mark Teo, et al.. (2019). Robust dose planning objectives for mesorectal radiotherapy of early stage rectal cancer – A multicentre dose planning study. Technical Innovations & Patient Support in Radiation Oncology. 11. 14–21. 11 indexed citations
10.
Teo, Mark, Lucy McParland, Ane Appelt, & David Sebag‐Montefiore. (2017). Phase 2 Neoadjuvant Treatment Intensification Trials in Rectal Cancer: A Systematic Review. International Journal of Radiation Oncology*Biology*Physics. 100(1). 146–158. 11 indexed citations
12.
Teo, Mark, David Sebag‐Montefiore, & Clare Donnellan. (2015). Prevention and Management of Radiation-induced Late Gastrointestinal Toxicity. Clinical Oncology. 27(11). 656–667. 30 indexed citations
13.
Ermiş, Ekin, et al.. (2015). Definitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55Gy in 20 fractions. Radiation Oncology. 10(1). 203–203. 29 indexed citations
14.
Teo, Mark, et al.. (2015). Definitive and adjuvant radiotherapy for sinonasal squamous cell carcinomas: a single institutional experience. Radiation Oncology. 10(1). 190–190. 27 indexed citations
15.
Teo, Mark, Lars Dyrskjøt, Jérémie Nsengimana, et al.. (2014). Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer. Annals of Oncology. 25(4). 877–883. 35 indexed citations
16.
Qiao, Boling, Martin Kerr, Blaž Grošelj, et al.. (2013). Imatinib Radiosensitizes Bladder Cancer by Targeting Homologous Recombination. Cancer Research. 73(5). 1611–1620. 30 indexed citations
17.
Teo, Mark, Debora Landi, Claire Taylor, et al.. (2011). The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes. Carcinogenesis. 33(3). 581–586. 91 indexed citations
18.
Teo, Mark, et al.. (2011). Enteral feeding outcomes after chemoradiotherapy for oropharynx cancer: A role for a prophylactic gastrostomy?. Oral Oncology. 48(5). 434–440. 46 indexed citations
19.
Qiao, Boling, Gina B. Scott, Sei Chung Sak, et al.. (2011). In vitro functional effects of XPC gene rare variants from bladder cancer patients. Carcinogenesis. 32(4). 516–521. 8 indexed citations
20.
Choudhury, Ananya, Mark Teo, Selina Bhattarai, et al.. (2010). MRE11 Expression Is Predictive of Cause-Specific Survival following Radical Radiotherapy for Muscle-Invasive Bladder Cancer. Cancer Research. 70(18). 7017–7026. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026